
    
      Design: Prospective, randomized, placebo-controlled, double-blinded study.

      Population: 60 patients with chronic active ulcerative colitis and steroid dependency

      Inclusion: Chronic active ulcerative colitis, clinical index 5 or more, endoscopic Index 5 or
      more, steroid dependent course since at least 4 months.

      Main criteria: complete steroid reduction
    
  